NCT06632041

Brief Summary

Haematological disturbances in neonates with necrotizing enterocolities

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 8, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

October 10, 2024

Status Verified

October 1, 2024

Enrollment Period

11 months

First QC Date

October 6, 2024

Last Update Submit

October 8, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Aim

    :to delineate haemtological abnormalities in neonatal necrotizing enterocolities as predictors of morbidity and mortality

    Baseline

Study Arms (1)

Neonates with necrotizing enterocolities

Diagnostic Test: Complete blood countOther: Complete blood count

Interventions

Complete blood countDIAGNOSTIC_TEST

Study haemtological disturbances in neonates with necrotizing enterocolities

Neonates with necrotizing enterocolities

Eligibility Criteria

Age1 Day - 30 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Neonates with necrotizing enterocolities

You may qualify if:

  • preterm less than 36 weeks
  • Or very low birth weight less than 1500 gram

You may not qualify if:

  • full term
  • Normal birth weight ,Preterm with early breast feeding or more than 1500 gm

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Blood Cell Count

Intervention Hierarchy (Ancestors)

Cell CountCytological TechniquesClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisHematologic TestsInvestigative TechniquesCell Physiological PhenomenaBlood Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Central Study Contacts

Mervat Maher Zakhary

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

October 6, 2024

First Posted

October 8, 2024

Study Start

January 1, 2025

Primary Completion

November 30, 2025

Study Completion

December 31, 2025

Last Updated

October 10, 2024

Record last verified: 2024-10